Our Team

Sean Cao, PhD, Cofounder and CEO

Sean is the CEO of Ensem and a Managing Director of CBC Group (formerly C-Bridge Capital), where he focuses on the incubation and strategy of new companies. Sean co-founded Everest Medicines, a biopharma company focused on developing innovative therapeutics in China and other Asian regions and served as its CEO during 2017 - 2020. Sean is also the Chairman of NiKang Therapeutics, a US based biotech incubated by CBC in 2017. Prior to CBC, Sean was VP of Global Business Development at Simcere Pharmaceutical Group, responsible for the global BD strategy, including licensing, acquisition, partnering and investment activities. Sean was also the President and Board Director at Simcere of America, a wholly owned subsidiary of Simcere. Prior to that, Sean was the Senior Director of Alternative Partnership, Evaluation & Expertise at Sanofi, where he led the externalization effort in Global R&D and managed the evaluation of acquisition/in-licensing opportunities. Before Sanofi, Sean was an Associate at New Leaf Venture Partners, a healthcare VC firm based in New York. Sean worked in the pharmaceutical and diagnostic industries over eight years at Aventis and Johnson & Johnson, before joining New Leaf.

Sean holds a PhD in Microbiology from the University of Virginia, an MBA with honor from the Wharton School of the University of Pennsylvania, and a BS in Microbiology from Nankai University, China.